Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review

Background: Cardiovascular disease (CVD) is one of the world’s leading causes of increased morbidity and mortality. Current interventions for CVD, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG), carry certain risks and complications, which...

Full description

Bibliographic Details
Published in:Current Stem Cell Research and Therapy
Main Author: Gan Q.F.; Lim Y.T.; Foo C.N.; Yu C.W.; Woon C.K.; Cheong S.K.; Leong P.P.
Format: Review
Language:English
Published: Bentham Science Publishers 2023
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132137625&doi=10.2174%2f1574888X17666220407085901&partnerID=40&md5=fddac04c5950b0635dbd439bda312f35
id 2-s2.0-85132137625
spelling 2-s2.0-85132137625
Gan Q.F.; Lim Y.T.; Foo C.N.; Yu C.W.; Woon C.K.; Cheong S.K.; Leong P.P.
Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
2023
Current Stem Cell Research and Therapy
18
2
10.2174/1574888X17666220407085901
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132137625&doi=10.2174%2f1574888X17666220407085901&partnerID=40&md5=fddac04c5950b0635dbd439bda312f35
Background: Cardiovascular disease (CVD) is one of the world’s leading causes of increased morbidity and mortality. Current interventions for CVD, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG), carry certain risks and complications, which may also affect the patient’s quality of life. It is important to minimize those risks and complications while speeding up the recovery. Insulin Growth Factor-1 (IGF-1) is a growth factor responsible for cellular migration, proliferation, differentiation, and angiogenesis, which supports cardiovascular regen-eration. Methods: In light of the current trend of regenerative medicine, the present review aims to pool data relat-ing to the incorporation of IGF-1 in regenerative medicine and provide input on the current research gaps and concerns arising on translating this approach from benchwork into clinical settings. Results: Using the keywords IGF-1 ‘OR’ Insulin Growth Factor 1 ‘AND’ Mesenchymal Stem Cells ‘AND’ Tissue Healing from 2009 to 2020, we identified 160 and 52 from Medline and PubMed, screen-ing out 202 articles due to non-fulfilment of the inclusion criteria. Conclusion: Incorporating IGF-1 into regenerative and personalized medicine may be promising for treating CVD; however, the concerns include the role of IGF-1 in inducing cancer growth and its ability to migrate to the specific site of injury, especially for those who present with multiple pathologies should be addressed prior to its translation from bench work into clinical settings. © 2023 Bentham Science Publishers.
Bentham Science Publishers
1574888X
English
Review

author Gan Q.F.; Lim Y.T.; Foo C.N.; Yu C.W.; Woon C.K.; Cheong S.K.; Leong P.P.
spellingShingle Gan Q.F.; Lim Y.T.; Foo C.N.; Yu C.W.; Woon C.K.; Cheong S.K.; Leong P.P.
Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
author_facet Gan Q.F.; Lim Y.T.; Foo C.N.; Yu C.W.; Woon C.K.; Cheong S.K.; Leong P.P.
author_sort Gan Q.F.; Lim Y.T.; Foo C.N.; Yu C.W.; Woon C.K.; Cheong S.K.; Leong P.P.
title Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
title_short Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
title_full Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
title_fullStr Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
title_full_unstemmed Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
title_sort Incorporating Insulin Growth Factor-1 into Regenerative and Personalized Medicine for Cardiovascular Disease: A Systematic Review
publishDate 2023
container_title Current Stem Cell Research and Therapy
container_volume 18
container_issue 2
doi_str_mv 10.2174/1574888X17666220407085901
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132137625&doi=10.2174%2f1574888X17666220407085901&partnerID=40&md5=fddac04c5950b0635dbd439bda312f35
description Background: Cardiovascular disease (CVD) is one of the world’s leading causes of increased morbidity and mortality. Current interventions for CVD, including percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG), carry certain risks and complications, which may also affect the patient’s quality of life. It is important to minimize those risks and complications while speeding up the recovery. Insulin Growth Factor-1 (IGF-1) is a growth factor responsible for cellular migration, proliferation, differentiation, and angiogenesis, which supports cardiovascular regen-eration. Methods: In light of the current trend of regenerative medicine, the present review aims to pool data relat-ing to the incorporation of IGF-1 in regenerative medicine and provide input on the current research gaps and concerns arising on translating this approach from benchwork into clinical settings. Results: Using the keywords IGF-1 ‘OR’ Insulin Growth Factor 1 ‘AND’ Mesenchymal Stem Cells ‘AND’ Tissue Healing from 2009 to 2020, we identified 160 and 52 from Medline and PubMed, screen-ing out 202 articles due to non-fulfilment of the inclusion criteria. Conclusion: Incorporating IGF-1 into regenerative and personalized medicine may be promising for treating CVD; however, the concerns include the role of IGF-1 in inducing cancer growth and its ability to migrate to the specific site of injury, especially for those who present with multiple pathologies should be addressed prior to its translation from bench work into clinical settings. © 2023 Bentham Science Publishers.
publisher Bentham Science Publishers
issn 1574888X
language English
format Review
accesstype
record_format scopus
collection Scopus
_version_ 1809678017348239360